Trust plans sale of 82,000 H common stock shares on NYSE
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
A shareholder associated with the MARK HOPLAMAZIAN REVOCABLE TRUST has filed a notice of proposed sale for 82,000 shares of common stock of the company with ticker H. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $13,623,570.20, and the form lists total shares outstanding as 41,819,241. The stock being sold comes from restricted stock and performance stock units that vested under a registered plan on 03/16/2022, 03/16/2023, 03/16/2025, and 03/04/2025, received as services rendered to the issuer. The filing also reports sales during the past three months, including 64,000 shares on 11/11/2025 and 63,500 shares on 11/10/2025, and confirms that the seller does not know of any material adverse, non-public information about the issuer's operations.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What recent sales of H stock by the Mark Hoplamazian Revocable Trust are disclosed?
What does the seller represent about knowledge of material non-public information?
AI-generated analysis. How Rhea-AI works. Not financial advice.